文献速递肝胆胰外科围术期管理与 ERAS

全胰腺切除联合门静脉内胰岛细胞自体移植治疗慢性胰腺炎的长期耐久性

How Durable Is Total Pancreatectomy and Intraportal Islet Cell Transplantation for Treatment of Chronic Pancreatitis?
PubMed 文献 · J Am Coll Surg · 2019-01-08

本研究为单中心观察性研究,纳入1998至2008年间接受全胰腺切除联合门静脉内胰岛细胞自体移植(TPIAT)且随访至少10年的215例慢性胰腺炎患者。10年实际生存率为72%,10年疼痛缓解率为82%,10年胰岛素不独立率为20%,部分移植物功能率为32%。移植胰岛当量/kg > 4000是10年移植物功能的最强预测因素。

要点

  • TPIAT可提供持久的疼痛缓解,10年缓解率达82%。
  • 10年胰岛素不独立率为20%,部分移植物功能率为32%。
  • 移植胰岛当量/kg > 4000是10年移植物功能的最强预测因素。

核心结论

  • TPIAT可产生持久的疼痛缓解和持续的胰岛移植物功能,即使术后超过10年。

研究设计与样本

  • 单中心观察性研究,纳入1998至2008年间在本中心接受TPIAT的215例患者,随访至少10年。

主要发现

  • 10年实际生存率为72%。
  • BMI > 30 kg/m2(p = 0.04)预测10年死亡率。
  • 10年疼痛缓解率为82%,15年疼痛缓解率为90%。
  • 麻醉药品使用率5年时为50%,10年时为37%。
  • 10年时胰岛素不独立率为20%,部分移植物功能率为32%。

关键数值与推荐

  • 部分移植物功能定义为C肽水平 > 0.6 mg/dL。
  • 无功能定义为C肽水平 < 0.6 mg/dL。

临床怎么用

  • 对于慢性胰腺炎患者,TPIAT可考虑作为提供持久疼痛缓解和胰岛功能维持的治疗选择。
  • 移植胰岛当量/kg > 4000可能有助于预测10年胰岛移植物功能。
  • 儿科患者可能从TPIAT中获得更好的胰岛功能结局。

局限性

  • 本研究为单中心观察性研究,结果可能受中心经验和患者选择影响。
  • 仅纳入1998至2008年间接受手术且随访至少10年的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A total pancreatectomy and intraportal islet cell autotransplant (TPIAT) is increasingly being offered to patients with chronic pancreatitis (CP). The benefits include removal of the root cause of pain and amelioration of diabetes. However, the long-term durability of this operation remains unclear. STUDY DESIGN: Of the 742 patients who have undergone a TPIAT at our center, 215 who did so between 1998 and 2008 now have at least 10 years of follow-up time and were eligible for this single-center observational study. Our outcomes measures included abdominal pain relief, narcotic use, islet graft function (subdivided into 3 groups: insulin independence; partial graft function, defined by C-peptide level > 0.6 mg/dL; and no function, defined by C-peptide level < 0.6 mg/dL), and health-related quality of life. RESULTS: The 10-year actuarial survival rate was 72%. A BMI > 30 kg/m2 (p = 0.04) predicted 10-year mortality. The rates of pain relief were 82% at 10 years and 90% at 15 years. Narcotic use declined with time: the rates were 50% at 5 years and 37% at 10 years. At 10 years, the rate of insulin independence was 20%; the rate of partial graft function, 32%. Transplantation of islet equivalents/kg > 4,000 was the strongest predictor of islet graft function at 10 years. Pediatric patients were more likely to have islet function than adults (p = 0.01). Health-related quality of life continued to improve at 10 years, even in patients on narcotics. CONCLUSIONS: This represents the first and largest series to examine long-term outcomes (10 years or more) in TPIAT patients. In our series, this dual procedure produced durable pain relief and sustained islet graft function, even past 10 years postoperatively.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Bellin MD, Beilman GJ, Sutherland DE, et al. How Durable Is Total Pancreatectomy and Intraportal Islet Cell Transplantation for Treatment of Chronic Pancreatitis? J Am Coll Surg. 2019. PMID: 30630085. doi:10.1016/j.jamcollsurg.2018.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。